Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
A large team of researchers led by Wouter Karthaus, head of the Endocrine Therapy Resistance and Molecular Genetics Lab at EPFL, and Eneda Toska at Johns Hopkins University have identified the enzyme ...
Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.
Adding docetaxel to androgen deprivation therapy (ADT) plus radiation therapy (RT) failed to improve survival in unfavorable-risk prostate cancer, though the combination may hold benefit for certain ...
The timing of breast cancer recurrence after mastectomy and adjuvant CMF chemotherapy supports a dormancy-based model for metastatic development BACKGROUND: Her2/neu and epidermal growth factor ...
Mutations in a genetic region that regulates RNA stability could influence prostate cancer outcomes and drug resistance, according to new work from scientists at Fred Hutchinson Cancer Center ...
A genitourinary oncologist provides insights on the treatment decision-making process and the roles of guidelines for prostate cancer. Alicia Morgans, MD, MPH: Treatment decisions for localized ...
Carrière Impressum Sitemap Choix de consentement Déclaration de confidentialité Conditions générales Publicité Home Suisse Sports Faits divers Monde People Loisirs Économie Société Santé & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results